LTR Pharma Ltd News

LTR Pharma Ltd: Annual Report to shareholders

ASXOct 28 14:07 · Announcements

LTR Pharma's SPONTAN 'Nasal Viagra' Absorbed 470% Times Faster Than Oral Solution

The Market HeraldOct 14 06:28

LTR Pharma Limited's (ASX:LTP) Biggest Owners Are Private Companies Who Got Richer After Stock Soared 14% Last Week

Yahoo FinanceSep 3 05:20

LTR Pharma Ltd: FY24 Results Announcement

Aug 30 07:29 · Announcements

LTR Pharma Ltd: Appendix 4E and Annual Financial Report

Aug 30 07:27 · Announcements

LTR Pharma Prescribes Erectile Dysfunction Medication Under Special Access Scheme

MT NewswiresAug 16 09:52

Why Is This ASX Small Cap Ripping 37% Ahead on Tuesday?

The Motley FoolAug 13 12:23

LTR Pharma, Aptar Pharma Enter Co-Development Agreement for SPONTAN Nasal Spray; LTR Shares Jump 18%

MT NewswiresAug 13 11:01

LTR Pharma Prescribes Erectile Dysfunction Medication in Australia Under Special Access Scheme

MT NewswiresAug 5 08:42

LTR Pharma's Nasal Spray Treatment for Erectile Dysfunction Obtains Positive Early Results in Trial; Shares Surge 33%

MT NewswiresJun 7 11:21

LTR Pharma Requests for Voluntary Suspension Pending Clinical Study Results

MT NewswiresJun 6 13:52

LTR Pharma Concludes Final Dose in SPONTAN Study

MT NewswiresMar 25 08:03

LTR Pharma Doses First SPONTAN Patients

MT NewswiresMar 19 06:43

LTR Pharma Launches Patient Recruitment for Erectile Dysfunction Drug Clinical Study

MT NewswiresFeb 19 08:37

LTR Pharma Receives Manufacturing Validation for SPONTAN Bioequivalence Study; Shares Down 3%

MT NewswiresFeb 6 08:41

LTR Pharma to Conduct Bioequivalence Clinical Trial for Spontan in Q1 2024

MT NewswiresDec 19, 2023 17:39

LTR Pharma to Start Trading on Australian Bourse Following AU$7 Million IPO

MT NewswiresDec 8, 2023 11:15